{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:01:50Z","timestamp":1780470110892,"version":"3.54.1"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Immunotherapy is considered the most promising approach for achieving complete tumor clearance in cancer treatment. However, monotherapy has demonstrated limited clinical efficacy, leading to a growing consensus that combination immunotherapy\u2014activating the immune system through multiple pathways\u2014appears to be the optimal strategy for enhancing therapeutic outcomes. In this study, we investigated the efficacy and underlying mechanisms of the combination immunotherapy MT\u2014comprising the TLR7\/8 agonist 3M-052 and the inhibitory anti-TNFR2 antibody\u2014in colon cancer (CRC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A CRC mouse model was established and divided into four treatment groups: the control group, the 3M-052 group, the anti-TNFR2 group, and the MT group. Tumour growth was monitored every three days. Flow cytometry was used to analyse the levels of CD8+ T cells and regulatory T cells (Tregs) in tumour tissue, as well as the differentiation of central memory T cells (Tcm) in the  tumor-draining lymph nodes  (TdLNs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The results revealed that the combination therapy MT promoted CD8+ T cell infiltration and reduced Tregs level within the tumor, effectively suppressed colon cancer growth in mice, and induced long-term syngeneic tumor control by enhancing the differentiation of Tcm in TdLNs. Compared with monotherapy, combination therapy MT demonstrated a superior capacity to induce the differentiation of central memory CD8+ and CD4+ T cells in TdLNs, an effect that appears to be primarily mediated by 3M-052.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This study demonstrates that the combination of 3M-052 and the anti-TNFR2 antibody exerts a synergistic effect, effectively inhibiting CRC progression and inducing long-term immune memory. Overall, these findings support the view that MT combination therapy represents a potentially effective strategy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1749062","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:05:18Z","timestamp":1780466718000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["3M-052 combined inhibitory anti-TNFR2 synergistically suppresses colon cancer progression"],"prefix":"10.3389","volume":"17","author":[{"given":"Qianyu","family":"Jing","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Chongqing Emergency Medical Center, School of Medicine, Chongqing University Central Hospital, Chongqing University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqian","family":"Luo","sequence":"additional","affiliation":[{"name":"The First People\u2019s Hospital of Jinzhong","place":["Jinzhong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Wan","sequence":"additional","affiliation":[{"name":"The University of Hong Kong-Shenzhen Hospital","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianjun","family":"Jing","sequence":"additional","affiliation":[{"name":"Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiefei","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Chongqing Emergency Medical Center, School of Medicine, Chongqing University Central Hospital, Chongqing University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Nei","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Chongqing Emergency Medical Center, School of Medicine, Chongqing University Central Hospital, Chongqing University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Chongqing Emergency Medical Center, School of Medicine, Chongqing University Central Hospital, Chongqing University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Chongqing Emergency Medical Center, School of Medicine, Chongqing University Central Hospital, Chongqing University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Chongqing Emergency Medical Center, School of Medicine, Chongqing University Central Hospital, Chongqing University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Chongqing Emergency Medical Center, School of Medicine, Chongqing University Central Hospital, Chongqing University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Chongqing Emergency Medical Center, School of Medicine, Chongqing University Central Hospital, Chongqing University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Nie","sequence":"additional","affiliation":[{"name":"Guizhou Provincial People\u2019s Hospital","place":["Guiyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Chongqing Emergency Medical Center, School of Medicine, Chongqing University Central Hospital, Chongqing University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Nie","sequence":"additional","affiliation":[{"name":"The University of Hong Kong-Shenzhen Hospital","place":["Shenzhen, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41392-020-00280-x","article-title":"The updated landscape of tumor microenvironment and drug repurposing","volume":"5","author":"Jin","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.07.009","article-title":"The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction","volume":"45","author":"Scharping","year":"2016","journal-title":"Immunity"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.72606","article-title":"TNFR2 deficiency impairs the growth of mouse colon cancer","volume":"19","author":"Li","year":"2023","journal-title":"Int J Biol Sci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2017.09.007","article-title":"TNFR2: A novel target for cancer immunotherapy","volume":"23","author":"Vanamee","year":"2017","journal-title":"Trends Mol Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0292-9","article-title":"Targeted killing of TNFR2-expressing tumor cells and Tregs by TNFR2 antagonistic antibodies in advanced S\u00e9zary syndrome","volume":"33","author":"Torrey","year":"2019","journal-title":"Leukemia"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1097090","article-title":"TNFR2 expression predicts the responses to immune checkpoint inhibitor treatments","volume":"14","author":"Liao","year":"2023","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aba9600","article-title":"A novel TNFR2 agonist antibody expands highly potent regulatory T cells","volume":"13","author":"Torrey","year":"2020","journal-title":"Sci Signal"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.1.154","article-title":"Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells","volume":"179","author":"Chen","year":"2007","journal-title":"J Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2100323","article-title":"TNFR2 signaling enhances suppressive abilities of human circulating T follicular regulatory cells","volume":"208","author":"Kawano","year":"2022","journal-title":"J Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.862154","article-title":"Targeting TNFR2: A novel breakthrough in the treatment of cancer","volume":"12","author":"Li","year":"2022","journal-title":"Front Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003508","article-title":"TNFR2 blockade of regulatory T cells unleashes an antitumor immune response after hematopoietic stem-cell transplantation","volume":"10","author":"Moatti","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax0720","article-title":"Antibody-mediated targeting of TNFR2 activates CD8+ T cells in mice and promotes antitumor immunity","volume":"11","author":"Tam","year":"2019","journal-title":"Sci Transl Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aan0790","article-title":"Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer","volume":"11","author":"Nie","year":"2018","journal-title":"Sci Signal"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.812774","article-title":"Toll-like receptor signaling and its role in cell-mediated immunity","volume":"13","author":"Duan","year":"2022","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2016.09.006","article-title":"Dendritic cells and cancer immunity","volume":"37","author":"Gardner","year":"2016","journal-title":"Trends Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14061228","article-title":"The role of toll-like receptor agonists and their nanomedicines for tumor immunotherapy","volume":"14","author":"Huang","year":"2022","journal-title":"Pharmaceutics"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s450205","article-title":"Regulating tumor-associated macrophage polarization by cyclodextrin-modified PLGA nanoparticles loaded with R848 for treating colon cancer","volume":"19","author":"Yuan","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/2051-1426-2-12","article-title":"Combination therapy targeting toll like receptors 7, 8 and 9 eliminates large established tumors","volume":"2","author":"Zhao","year":"2014","journal-title":"J Immunother Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2022.102172","article-title":"Toll-like receptor (TLR) agonists as a driving force behind next-generation vaccine adjuvants and cancer therapeutics","volume":"70","author":"Kaur","year":"2022","journal-title":"Curr Opin Chem Biol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s40425-019-0724-8","article-title":"Intratumoral immunotherapy with TLR7\/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies","volume":"7","author":"Mullins","year":"2019","journal-title":"J\u00a0Immunother Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abb1025","article-title":"3M-052, a synthetic TLR-7\/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primates","volume":"5","author":"Kasturi","year":"2020","journal-title":"Sci Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-024-04966-6","article-title":"Combinational delivery of TLR4 and TLR7\/8 agonist enhanced the therapeutic efficacy of immune checkpoint inhibitors to colon tumor","volume":"480","author":"Wang","year":"2024","journal-title":"Mol Cell Biochem"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nri1845","article-title":"Dendritic cells in a mature age","volume":"6","author":"Reis e Sousa","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.12.002","article-title":"CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor","volume":"56","author":"Prokhnevska","year":"2023","journal-title":"Immunity"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800016","article-title":"IL-6 promotes T cell proliferation and expansion under inflammatory conditions in association with low-level ROR\u03b3t expression","volume":"201","author":"Li","year":"2018","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2023.08.001","article-title":"The exercise IL-6 enigma in cancer","volume":"34","author":"Orange","year":"2023","journal-title":"Trends Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-023-01580-3","article-title":"Inhalable extracellular vesicle delivery of IL-12 mRNA to treat lung cancer and promote systemic immunity","volume":"19","author":"Liu","year":"2024","journal-title":"Nat\u00a0Nanotechnol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.4c00063","article-title":"Delivery of mRNA encoding interleukin-12 and a stimulator of interferon genes agonist potentiates antitumor efficacy through reversing T cell exhaustion","volume":"18","author":"Wang","year":"2024","journal-title":"ACS Nano"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-024-00889-9","article-title":"Systemic IFN-I combined with topical TLR7\/8 agonists promotes distant tumor suppression by c-Jun-dependent IL-12 expression in dendritic cells","volume":"6","author":"Sanlorenzo","year":"2025","journal-title":"Nat Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2174\/1568009614666140828103253","article-title":"The role of dendritic cells in cancer","volume":"348","author":"Lee","year":"2019","journal-title":"Int Rev Cell Mol Biol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.669474","article-title":"Differentiation and regulation of T(H) cells: A balancing act for cancer immunotherapy","volume":"12","author":"Basu","year":"2021","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40364-020-00228-x","article-title":"Roles of IFN-\u03b3 in tumor progression and regression: A review","volume":"8","author":"Jorgovanovic","year":"2020","journal-title":"biomark Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"4665","DOI":"10.1038\/s41467-024-49059-6","article-title":"Glycolysis inhibition induces anti-tumor central memory CD8+T cell differentiation upon combination with microwave ablation therapy","volume":"15","author":"Tang","year":"2024","journal-title":"Nat Commun"},{"key":"B34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.trecan.2023.09.006","article-title":"The tumor-draining lymph node as a reservoir for systemic immune surveillance","volume":"10","author":"Delclaux","year":"2024","journal-title":"Trends Cancer"},{"key":"B35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cellimm.2019.03.002","article-title":"T-memory cells against cancer: Remembering the enemy","volume":"338","author":"Sarkar","year":"2019","journal-title":"Cell Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0033-2","article-title":"Proliferation tracing with single-cell mass cytometry optimizes generation of stem cell memory-like T cells","volume":"37","author":"Good","year":"2019","journal-title":"Nat Biotechnol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0791-5","article-title":"Two subsets of stem-like CD8(+) memory T cell progenitors with distinct fate commitments in humans","volume":"21","author":"Galletti","year":"2020","journal-title":"Nat Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-020-00707-9","article-title":"Memory T cells: Strategies for optimizing tumor immunotherapy","volume":"11","author":"Liu","year":"2020","journal-title":"Protein Cell"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.723888","article-title":"Immunotherapeutic potential of T memory stem cells","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2147\/jir.s343432","article-title":"Tumor-infiltrating CD4(+) central memory T cells correlated with favorable prognosis in oral squamous cell carcinoma","volume":"15","author":"Wu","year":"2022","journal-title":"J Inflammation Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.09.020","article-title":"The primordial differentiation of tumor-specific memory CD8+ T cells as bona fide responders to PD-1\/PD-L1 blockade in draining lymph nodes","volume":"185","author":"Huang","year":"2022","journal-title":"Cell"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1749062\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:05:20Z","timestamp":1780466720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1749062\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":41,"alternative-id":["10.3389\/fimmu.2026.1749062"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1749062","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"article-number":"1749062"}}